ENTITY
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals (REGN US)

128
Analysis
Health CareUnited States
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
more
Company Event11 Sep 2023 21:20 • Latest
Company Event06 Sep 2023 20:45
Company Event16 May 2023 21:30
Company Event10 May 2023 04:40
x